RecruitingNot ApplicableNCT04286308
Cortical-Basal Ganglia Speech Networks
Sponsor
Massachusetts General Hospital
Enrollment
80 participants
Start Date
Oct 1, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
In this research study the researchers want to learn more about brain activity related to speech perception and production.
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Plain Language Summary
Simplified for easier understanding
This study records brain activity during speech in patients who are already undergoing deep brain stimulation (DBS) surgery for movement disorders like Parkinson's disease, essential tremor, or dystonia. Researchers want to understand how the brain's speech networks interact with the basal ganglia (a region deep in the brain) to improve future treatments.
**You may be eligible if...**
- You are scheduled to have deep brain stimulation (DBS) surgery, as recommended by a specialist team
- Your diagnosis is Parkinson's disease, essential tremor, or dystonia
- You are between 18 and 85 years old
- You can follow instructions and provide consent
**You may NOT be eligible if...**
- You have significant hearing loss
- You are not an English speaker
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERelectrophysiological data collection
Electrophysiological data collection at the time of DBS surgery.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04286308
Related Trials
Brain Training to Improve Balance in Parkinson's Disease
NCT059866431 location
tDCS on Parkinson's Disease Cognition
NCT030253341 location
Magnetoencephalography (MEG) Pilot Study
NCT074461921 location
The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
NCT034574931 location
World Data on Ambroxol for Patients With GD and GBA Related PD
NCT043889693 locations